Nordic Issuing

Ongoing case

Monivent AB

Back to all cases

Monivent AB

11 Feb - 4 Mar 2021Warrant exercise TO 1

Monivent is a young Medtech company focused on improving the care given to newborn babies in need of respiratory support at birth.

Monivent has developed a unique and patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. This unique and appreciated feature eliminates the need for additional cables and tubes at the resuscitation table. The face mask and the sensor module are connected to the existing ventilation equipment, causing minimal impact on current routines. When the airflow passes through the mask and sensor module, a measurable pressure differential is formed. Through Monivent’s proprietary algorithms the pressure difference can be converted to exact flows and volumes.

Read more at the Company's website


The offer in summary

Terms: One (1) warrant of serier TO 1 will give the holder the right to subscribe for one (1) new share in Monivent AB

Subscription price: 8.20 SEK

Number of warrants series TO 1: 907 866

Marketplace: Spotlight Stock Market

Disclaimer

Due to restrictions in applicable law in the United States, Canace, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.